Retraction notice to "Comparative proteomics reveals deficiency of NHE-1 (Slc9a1) in RBCs from the beta-adducin knockout mouse model of hemolytic anemia" [Blood Cells Mol. Dis. 47 (2011) 85-94];Comparative proteomics reveals deficiency of NHE-1 (Slc9a1) in RBCs from the beta-adducin knockout mouse model of hemolytic anemia

Blood Cells, Molecules, and Diseases

Volumn 47, Issue 2, 2011, Pages 85-94

  Gilligan, Diana M ^a   Finney, Greg L ^b   Rynes, Eric ^b   MacCoss, Michael J ^b   Lambert, Amy J ^c   Peters, Luanne L ^c   Robledo, Raymond F ^c   Wooden, Jason M ^d  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c JACKSON LABORATORY   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

Author keywords

Adducin; Anemia; Label free proteomics; NHE 1; Red blood cell; Reticulocyte

Indexed keywords

ADDUCIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA ADDUCIN; BETA ADDUCIN; BETA3 INTEGRIN; CALNEXIN; CARRIER PROTEINS AND BINDING PROTEINS; CD71 ANTIGEN; CD98 ANTIGEN; CHAPERONIN CONTAINING TCP1; ERYTHROCYTE BAND 4.1 PROTEIN; FODRIN; GAMMA ADDUCIN 3; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK COGNATE PROTEIN 71; HEAT SHOCK PROTEIN; HEMOGLOBIN A; HEMOGLOBIN BETA CHAIN; HISTONE H2B; PHENYLHYDRAZINE; POLYADENYLIC ACID BINDING PROTEIN; POLYADENYLIC ACID BINDING PROTEIN 1; PROTEIN CAPZ; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; SOLUTE CARRIER FAMILY 14 MEMBER 1; THROMBOCYTE FACTOR 4; TROPOMODULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HEMOLYTIC ANEMIA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RETICULOCYTE; RETICULOCYTOSIS;

MUS;

EID: 79960841051     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2011.12.007     Document Type: Erratum

References (55)

1. Bennett V., Gilligan D.M. The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu. Rev. Cell Biol. 1993, 9:27-66.
2. Chasis J.A., Mohandas N. Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations. J. Cell Biol. 1986, 103(2):343-350.
3. Mohandas N., Chasis J.A. Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin. Hematol. 1993, 30(3):171-192.
4. Palek J., Lux S.E. Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias. Semin. Hematol. 1983, 20(3):189-224.
5. Birkenmeier C.S., Barker J.E. Hereditary haemolytic anaemias: unexpected sequelae of mutations in the genes for erythroid membrane skeletal proteins. J. Pathol. 2004, 204(4):450-459.
6. Iolascon A., Perrotta S., Stewart G. Red blood cell membrane defects. Rev. Clin. Exp. Hematol. 2003, 1:22-56.
7. Peters L.L., et al. Identification of quantitative trait loci that modify the severity of hereditary spherocytosis in wan, a new mouse model of band-3 deficiency. Blood 2004, 103(8):3233-3240.
8. Hattangadi S.M., Lodish H.F. Regulation of erythrocyte lifespan: do reactive oxygen species set the clock?. J. Clin. Invest. 2007, 117(8):2075-2077.
9. Marinkovic D., et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J. Clin. Invest. 2007, 117(8):2133-2144.
10. Friedman J.S., et al. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood 2004, 104(8):2565-2573.
11. Lowenson J., Clarke S. Does the chemical instability of aspartyl and asparaginyl residues in proteins contribute to erythrocyte aging? The role of protein carboxyl methylation reactions. Blood Cells 1988, 14(1):103-118.
12. Lowenson J.D., Clarke S. Structural elements affecting the recognition of L-isoaspartyl residues by the L-isoaspartyl/D-aspartyl protein methyltransferase. Implications for the repair hypothesis. J. Biol. Chem. 1991, 266(29):19396-19406.
13. Peters L., Barker J. Spontaneous and targeted mutations in erythrocyte membrane skeleton genes: mouse models of hereditary spherocytosis. Clinical Medicine 2001, 582-608. Oxford Press, New York. L.I. Zon (Ed.).
14. Eber S., Lux S.E. Hereditary spherocytosis-defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin. Hematol. 2004, 41(2):118-141.
15. Barker JE B.D., Birkenmeier C.S. Synthesis of spectrin and its assembly into the red blood cell cytoskeleton of normal and mutant mice. Membrane Skeletons and Cytoskeletal-Membrane Associations 1986, 313-324. Liss, New York, NY. V. Beneet, S.E. Lux, C.M. Cohen, J. Palek (Eds.).
16. Hassoun H., et al. Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene. Blood 1998, 91(6):2146-2151.
17. Peters L.L., et al. Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice. J. Clin. Invest. 1999, 103(11):1527-1537.
18. Gilligan D.M., et al. Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(19):10717-10722.
19. Gardner K., Bennett V. A new erythrocyte membrane-associated protein with calmodulin binding activity. Identification and purification. J. Biol. Chem. 1986, 261(3):1339-1348.
20. Muro A.F., et al. Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood 2000, 95(12):3978-3985.
21. Pasini E.M., et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006, 108(3):791-801.
22. Kruger M., et al. SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 2008, 134(2):353-364.
23. Finney G.L., et al. Label-free comparative analysis of proteomics mixtures using chromatographic alignment of high-resolution muLC-MS data. Anal. Chem. 2008, 80(4):961-971.
24. Beutler E., West C., Blume K.G. The removal of leukocytes and platelets from whole blood. J. Lab. Clin. Med. 1976, 88(2):328-333.
25. Beutler E., Gelbart T. The mechanism of removal of leukocytes by cellulose columns. Blood Cells 1986, 12(1):57-64.
26. Chui D.H., Patterson M., Bayley S.T. Unequal alpha and beta globin mRNA in reticulocytes of normal and mutant f/f fetal mice. Br. J. Haematol. 1980, 44(3):431-439.
27. Storey J.D., Tibshirani R. Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol. Biol. 2003, 224:149-157.
28. Kall L., et al. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat. Methods 2007, 4(11):923-925.
29. Kakhniashvili D.G., Bulla L.A., Goodman S.R. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol. Cell. Proteomics 2004, 3(5):501-509.
30. Campanella M.E., Chu H., Low P.S. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(7):2402-2407.
31. Prenni J.E., Avery A.C., Olver C.S. Proteomics: a review and an example using the reticulocyte membrane proteome. Vet. Clin. Pathol. 2007, 36(1):13-24.
32. Hughes C.A., Bennett V. Adducin: a physical model with implications for function in assembly of spectrin-actin complexes. J. Biol. Chem. 1995, 270(32):18990-18996.
33. Porro F., et al. The erythrocyte skeletons of beta-adducin deficient mice have altered levels of tropomyosin, tropomodulin and EcapZ. FEBS Lett. 2004, 576(1-2):36-40.
34. Tse W.T., Lux S.E. Red blood cell membrane disorders. Br. J. Haematol. 1999, 104(1):2-13.
35. Chen H., et al. Combined deletion of mouse dematin-headpiece and beta-adducin exerts a novel effect on the spectrin-actin junctions leading to erythrocyte fragility and hemolytic anemia. J. Biol. Chem. 2007, 282(6):4124-4135.
36. Rizvi S.I., Zaid M.A. Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins. Clin. Chim. Acta 2005, 354(1-2):59-67.
37. Tempel B.L., Shilling D.J. The plasma membrane calcium ATPase and disease. Subcell. Biochem. 2007, 45:365-383.
38. Delaunay J. The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations. Semin. Hematol. 2004, 41(2):165-172.
39. Stewart G.W., et al. Isolation of cDNA coding for an ubiquitous membrane protein deficient in high Na+, low K+ stomatocytic erythrocytes. Blood 1992, 79(6):1593-1601.
40. Fricke B., et al. The "stomatin" gene and protein in overhydrated hereditary stomatocytosis. Blood 2003, 102(6):2268-2277.
41. Zhu Y., et al. Stomatocytosis is absent in "stomatin"-deficient murine red blood cells. Blood 1999, 93(7):2404-2410.
42. Snyers L., Umlauf E., Prohaska R. Association of stomatin with lipid-protein complexes in the plasma membrane and the endocytic compartment. Eur. J. Cell Biol. 1999, 78(11):802-812.
43. Rose Z.B. The enzymology of 2,3-bisphosphoglycerate. Adv. Enzymol. Relat. Areas Mol. Biol. 1980, 51:211-253.
44. Koliakos G., Paletas K., Kaloyianni M. NHE-1: a molecular target for signalling and cell matrix interactions. Connect. Tissue Res. 2008, 49(3):157-161.
45. Lew V.L., et al. Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells. Blood 2003, 102(12):4206-4213.
46. Vanagas L., et al. Plasma membrane calcium pump activity is affected by the membrane protein concentration: evidence for the involvement of the actin cytoskeleton. Biochim. Biophys. Acta 2007, 1768(6):1641-1649.
47. Pritlove D.C., et al. Novel placental expression of 2,3-bisphosphoglycerate mutase. Placenta 2006, 27(8):924-927.
48. Aizawa S., et al. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity. Exp. Hematol. 2005, 33(11):1292-1298.
49. Aisaki K., et al. Glycolytic inhibition by mutation of pyruvate kinase gene increases oxidative stress and causes apoptosis of a pyruvate kinase deficient cell line. Exp. Hematol. 2007, 35(8):1190-1200.
50. Low F.M., Hampton M.B., Winterbourn C.C. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid. Redox Signal. 2008, 10(9):1621-1630.
51. Lee T.H., et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 2003, 101(12):5033-5038.
52. Rocha S., et al. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol. Dis. 2008, 41(1):5-9.
53. Rocha S., et al. Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress. Blood Cells Mol. Dis. 2009, 43(1):68-73.
54. Robledo R.F., et al. Targeted deletion of alpha-adducin results in absent beta- and gamma-adducin, compensated hemolytic anemia, and lethal hydrocephalus in mice. Blood 2008, 112:4298-4307.
55. Robledo R.F., et al. Analysis of novel sph (spherocytosis) alleles in mice reveals allele-specific loss of band 3 and adducin in alpha-spectrin-deficient red cells. Blood 2010, 115:1804-1814.